Alkem Laboratories gains as its arm to acquire 100% stake in Bombay Ortho
Alkem Laboratories is currently trading at Rs. 4750.00, up by 45.90 points or 0.98% from its previous closing of Rs. 4704.10 on the BSE.
The scrip opened at Rs. 4768.95 and has touched a high and low of Rs. 4829.75 and Rs. 4733.50 respectively. So far 996 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 6440.00 on 17-Sep-2024 and a 52 week low of Rs. 4409.90 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 4829.75 and Rs. 4609.50 respectively. The current market cap of the company is Rs. 56967.94 crore.
The promoters holding in the company stood at 55.66%, while Institutions and Non-Institutions held 28.16% and 16.18% respectively.
Alkem Laboratories’ wholly owned subsidiary -- M/s. Alkem Medtech has executed Share Purchase and Share Subscription Agreement with M/s. Bombay Ortho Industries (Bombay Ortho) to acquire 100% stake in Bombay Ortho.
The proposed investment by Alkem MedTech is a strategic investment which will help to gain manufacturing capabilities to participate in growing orthopedic space and leveraging Bombay Ortho’s expertise within the Hip and Knee implants segment.
Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.
